Eversept Partners »

Vir Biotechnology shares owned by Eversept Partners

Quarter-by-quarter ownership of Vir Biotechnology (VIR) shares owned by Eversept Partners from 13F filings

Historical chart of Eversept Partners investment in Vir Biotechnology

Tip: Access up to 7 years of quarterly data

All positions including Vir Biotechnology held by Eversept Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vir Biotechnology by Eversept Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.2M 250k 8.96

More positions owned by Eversept Partners

United Therapeutics Corporation (UTHR)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Abivax Sa Sponsored Ads (ABVX)
GSK Sponsored Adr (GSK)
Vera Therapeutics Cl A (VERA)
Natera (NTRA)
State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Syndax Pharmaceuticals (SNDX)
Celldex Therapeutics Com New (CLDX)
Vaxcyte (PCVX)
Brookdale Senior Living (BKD)
Ionis Pharmaceuticals (IONS)
Qiagen Nv Ord Shares (QGEN)
Vertex Pharmaceuticals Incorporated Call Option (VRTX)
Hca Holdings (HCA)

View all positions for Eversept Partners

Top funds holding Vir Biotechnology

BlackRock
Arch Venture Corp
Sb Investment Advisers
Vanguard Portfolio Management
State Street Corporation
Vanguard Capital Management
Goldman Sachs Group
Morgan Stanley
ADAR1 Capital Management
Geode Capital Management
Dimensional Fund Advisors
Citadel Advisors
FMR
Soleus Capital Management
Point72 Asset Management

View all funds holding Vir Biotechnology